Informed consent procedures and information about potential side effects of newly prescribed treatments present a classic dilemma. Although providing information about potential risks and side effects is necessary both from a medicolegal perspective and to maintain patient autonomy in a shared decision-making process, it can fuel patients’ worries and negative expectations. Ulrike Bingel and Katja Wiech discuss these topics in their comment, which you can read here.